Trexquant Investment LP Cue Biopharma, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.49 - $5.92 $99,774 - $237,214	-40,070 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.41 - $12.28 $176,708 - $492,059	40,070 New	40,070 $196,000
Q3 2021 Nov 12, 2021	SELL	$10.06 - $15.3 $351,446 - $534,505	-34,935 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.9 - $14.53 $104,650 - $139,502	9,601 Added 37.9%	34,935 $407,000
Q1 2021 May 13, 2021	BUY	$11.2 - $16.09 $89,622 - $128,752	8,002 Added 46.17%	25,334 $309,000
Q4 2020 Feb 11, 2021	BUY	$11.12 - $16.4 $34,583 - $51,003	3,110 Added 21.87%	17,332 $217,000
Q3 2020 Nov 06, 2020	SELL	$15.05 - $23.54 $29,663 - $46,397	-1,971 Reduced 12.17%	14,222 $214,000
Q2 2020 Aug 07, 2020	BUY	$12.7 - $30.73 $49,631 - $120,092	3,908 Added 31.81%	16,193 $397,000
Q1 2020 May 08, 2020	BUY	$9.85 - $22.27 $121,007 - $273,586	12,285 New	12,285 $174,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $36.1M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.